/
HYFT
$1.66+$0.08 (+5.06%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$73.8M
47M shares
52-week range
$0.99 – $2.99
34% from low
Exchange
NASDAQ
CS
Borrow rate
1.15%
Moderate
Price (6 mo)
Loading chart…
Change$-0.33
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4M | $10.9M | $14.7M | $17.9M | $19.4M | $20.7M | $24.5M | $24.5M |
| Cost of revenue | $3.0M | $5.6M | $15.3M | $6.4M | $8.4M | $9.1M | $12.5M | $11.0M |
| Gross profit | $2.5M | $5.3M | −$576.3K | $11.5M | $11.0M | $11.6M | $12.1M | $13.5M |
| Gross margin | 45.0% | 48.5% | -3.9% | 64.4% | 56.7% | 56.0% | 49.2% | 55.3% |
| R&D | $509.2K | $485.8K | $467.3K | $2.0M | $7.7M | $14.1M | $4.0M | $4.9M |
| Operating income | −$4.9M | −$6.2M | −$4.3M | −$4.2M | −$16.7M | −$25.6M | −$13.8M | −$12.2M |
| EBITDA | −$4.3M | −$4.0M | −$1.2M | −$1.4M | −$12.0M | −$21.0M | −$22.9M | −$28.9M |
| Net income | −$5.2M | −$7.6M | −$5.2M | −$7.3M | −$16.7M | −$26.6M | −$26.1M | −$30.2M |
| Net margin | -95.0% | -69.7% | -35.2% | -41.0% | -86.3% | -128.5% | -106.5% | -123.3% |
| EPS (diluted) | -0.57 | -0.61 | -0.36 | -0.45 | -0.87 | -1.07 | -1.03 | -0.90 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $20M | $-0.24 | $-0.24–$-0.24 | 1 |
| 2028 | $25M | $-0.16 | $-0.18–$-0.14 | 2 |
| 2029 | $31M | $-0.06 | $-0.10–$-0.02 | 2 |
| 2030 | $38M | $0.05 | $0.05–$0.05 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
MindWalk Holdings Corp. Common Stock
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
www.mindwalkai.com- Employees
- 102
- IPO / List date
- Jul 16, 2010
Held by traders on TradeandTell
No one on the platform currently holds HYFT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 232,480 | $262.7K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HYFT yet.
